Reducing Hereditary Cancer Act

Hozzl · 2024-12-21T09:05:44Z

Explore the details of House Bill 1526 Reducing Hereditary Cancer Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/21/2024, 9:05 AM

Summary of Bill HR 1526

Bill 118 HR 1526, also known as the Reducing Hereditary Cancer Act, is a piece of legislation introduced in the US Congress. The main goal of this bill is to address the issue of hereditary cancer by providing increased access to genetic testing and counseling for individuals who may be at risk.

The bill proposes to establish a grant program that would provide funding to healthcare providers to offer genetic testing and counseling services to individuals with a family history of certain types of cancer. This would help identify individuals who may be at an increased risk of developing hereditary cancer and allow them to take proactive steps to manage their risk.

Additionally, the bill aims to improve education and awareness around hereditary cancer by requiring the Department of Health and Human Services to develop and implement a public education campaign. This campaign would provide information on the importance of genetic testing and counseling for individuals with a family history of cancer. Overall, the Reducing Hereditary Cancer Act seeks to address the issue of hereditary cancer by increasing access to genetic testing and counseling services, as well as improving education and awareness around the topic. This bill has the potential to have a significant impact on individuals at risk for hereditary cancer and could help save lives through early detection and prevention measures.

Congressional Summary of HR 1526

Reducing Hereditary Cancer Act

This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 1526

Bill HR 1526 is currently in the status of Bill Introduced since March 9, 2023. Bill HR 1526 was introduced during Congress 118 and was introduced to the House on March 9, 2023. Bill HR 1526's most recent activity was Referred to the Subcommittee on Health. as of December 17, 2024

Bipartisan Support of Bill HR 1526

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

114

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 1526

Primary Policy Focus

Health

Potential Impact Areas

- Cancer

- Genetics

- Health care coverage and access

- Health promotion and preventive care

- Hereditary and development disorders

- Medical tests and diagnostic methods

- Medicare

Alternate Title(s) of Bill HR 1526

Reducing Hereditary Cancer Act

To amend title XVIII of the Social Security Act to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation in a blood relative or a personal or ancestral history suspicious for hereditary cancer, and to provide coverage of certain cancer screenings or preventive surgeries that would reduce the risk for individuals with a germline (inherited) mutation associated with a high risk of developing a preventable cancer.